Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His had a long list, unfortunately closed by his passing away at the age of 92 ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

From evolving scam psychology to emerging AI privacy risks, here's what's on our radar ahead of this year's RSAC Conference ...

Costumed beasts and creepy crawlies aren’t limited to Halloween. This week a wild and woolly band of bloodthirsty space ...

In the last few years, Chinese AI startup MiniMax has become one of the most exciting in the crowded global AI marketplace, ...

Karpathy 上了 No Priors 播客，和 Sarah Guo 聊了一个多小时。 播客信息密度极高，从 Agent 工作流到 AutoResearch，从就业市场到开源与闭源，从机器人到教育，几乎覆盖了 AI 当下所有热门话题。 从 12 ...

Although the firms were Japanese, the delegation comprised representatives from India, Turkey, Britain and Saudi Arabia as ...

Balancing nitrogen use is critical for maximizing crop yield while minimizing environmental and economic costs. A new approach integrates drone-based multispectral imaging with machine learning to ...

Director Corey Andrew Barr explains why the upcoming edition will be the fair’s boldest, most forward-looking chapter yet.